Real-time enrollment status for this fragile x syndrome clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 1:52 AM UTC
| NCT Number | NCT07209462 |
| Recruiting Status | Recruiting |
| Condition | Fragile X Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 15 sites in the US |
| Sponsor | Mirum Pharmaceuticals, Inc. |
| Last Updated on CT.gov | August 24, 2026 (5 days ago) |
As of August 29, 2026: Clinical trial NCT07209462 is currently recruiting participants. This phase2 study for fragile x syndrome is actively seeking new participants at 15 locations across the United States. The study is sponsored by Mirum Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07209462 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 15 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07209462 was last updated 5 days ago (August 24, 2026). HelloStudys verifies this status automatically.